Insider Buy/Sell Details for the Healthcare Sector — March 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1826)
CytomX Therapeutics, Inc. (CTMX)
Ogden Christopher — Chief Financial Officer
Shares
19,323
Price
$6.42
Total Value
$124.11K
Shares Held After
296,948
% of Holdings
6.1%
CytomX Therapeutics, Inc. (CTMX)
McCarthy Sean A. — Director
Shares
118,969
Price
$6.42
Total Value
$764.14K
Shares Held After
1,078,922
% of Holdings
9.9%
CytomX Therapeutics, Inc. (CTMX)
BELVIN MARCIA — SVP, Chief Scientific Officer
Shares
31,492
Price
$6.42
Total Value
$202.27K
Shares Held After
300,760
% of Holdings
9.5%
Roivant Sciences Ltd. (ROIV)
Venker Eric — President & Immunovant CEO
Shares
200,000
Price
$28.24
Total Value
$5.65M
Shares Held After
1,647,546
% of Holdings
10.8%
Enliven Therapeutics, Inc. (ELVN)
Collins Helen Louise — CHIEF MEDICAL OFFICER
Shares
5,000
Price
$27.76
Total Value
$138.80K
Shares Held After
25,000
% of Holdings
16.7%
Pacira BioSciences, Inc. (PCRX)
Froimson Mark — Director
Shares
500
Price
$21.81
Total Value
$10.90K
Shares Held After
20,136
% of Holdings
2.4%
Stoke Therapeutics, Inc. (STOK)
Allan Jonathan — GENERAL COUNSEL & CORP SEC
Shares
1,791
Price
$33.38
Total Value
$59.78K
Shares Held After
33,464
% of Holdings
5.1%
Pacira BioSciences, Inc. (PCRX)
SLONIN JONATHAN — Chief Medical Officer
Shares
3,261
Price
$22.82
Total Value
$74.42K
Shares Held After
223,640
% of Holdings
1.4%
Stoke Therapeutics, Inc. (STOK)
Allan Jonathan — GENERAL COUNSEL & CORP SEC
Shares
2,476
Price
$32.74
Total Value
$81.06K
Shares Held After
35,255
% of Holdings
6.6%
Stoke Therapeutics, Inc. (STOK)
Hoitt Jason — Chief Patient Officer
Shares
748
Price
$33.38
Total Value
$24.96K
Shares Held After
12,207
% of Holdings
5.8%
Stoke Therapeutics, Inc. (STOK)
Hoitt Jason — Chief Patient Officer
Shares
1,033
Price
$32.74
Total Value
$33.82K
Shares Held After
12,955
% of Holdings
7.4%
Stoke Therapeutics, Inc. (STOK)
Leggett Thomas — Chief Financial Officer
Shares
922
Price
$33.38
Total Value
$30.77K
Shares Held After
12,554
% of Holdings
6.8%
Stoke Therapeutics, Inc. (STOK)
Leggett Thomas — Chief Financial Officer
Shares
1,274
Price
$32.74
Total Value
$41.71K
Shares Held After
13,476
% of Holdings
8.6%
Stoke Therapeutics, Inc. (STOK)
Ticho Barry — CHIEF MEDICAL OFFICER
Shares
2,587
Price
$33.38
Total Value
$86.34K
Shares Held After
47,484
% of Holdings
5.2%
Stoke Therapeutics, Inc. (STOK)
Ticho Barry — CHIEF MEDICAL OFFICER
Shares
3,577
Price
$32.74
Total Value
$117.11K
Shares Held After
50,071
% of Holdings
6.7%
Medpace Holdings, Inc. (MEDP)
GEIGER JESSE J — President
Shares
31,707
Price
$455.30
Total Value
$14.44M
Shares Held After
15,000
% of Holdings
67.9%
CORCEPT THERAPEUTICS INC (CORT)
BAKER G LEONARD JR — Director
Shares
24,218
Price
$33.56
Total Value
$812.84K
Shares Held After
1,146,631
% of Holdings
2.1%
CORCEPT THERAPEUTICS INC (CORT)
BAKER G LEONARD JR — Director
Shares
75,782
Price
$33.00
Total Value
$2.50M
Shares Held After
1,122,413
% of Holdings
6.8%
KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS)
Webster Brian Daniel — Director
Shares
15,000
Price
$20.27
Total Value
$304.12K
Shares Held After
364,786
% of Holdings
3.9%
GLAUKOS Corp (GKOS)
Thurman Alex R. — SVP & CHIEF FINANCIAL OFFICER
Shares
625
Price
$99.15
Total Value
$61.97K
Shares Held After
49,249
% of Holdings
1.3%
INCYTE CORP (INCY)
CAGNONI PABLO J — President, R&D
Shares
18,667
Price
$94.24
Total Value
$1.76M
Shares Held After
234,800
% of Holdings
7.4%
CASTLE BIOSCIENCES INC (CSTL)
MAETZOLD DEREK J — Director
Shares
18,650
Price
$25.93
Total Value
$483.59K
Shares Held After
22,129
% of Holdings
45.7%
Orthofix Medical Inc. (OFIX)
Vitale Lucas — CP&BOO
Shares
4,269
Price
$11.92
Total Value
$50.89K
Shares Held After
160,449
% of Holdings
2.6%
PROCEPT BioRobotics Corp (PRCT)
Nouri Alaleh — EVP, CLO, CORP. SEC.
Shares
304
Price
$28.15
Total Value
$8.56K
Shares Held After
110,717
% of Holdings
0.3%
PROCEPT BioRobotics Corp (PRCT)
Waters Kevin — EVP, CFO
Shares
706
Price
$28.15
Total Value
$19.88K
Shares Held After
151,558
% of Holdings
0.5%
TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)
Sabag Mark — See "Remarks"
Shares
62,102
Price
$30.14
Total Value
$1.87M
Shares Held After
224,940
% of Holdings
21.6%
Zai Lab Ltd (ZLAB)
GAYNOR RICHARD — Director
Shares
1,731
Price
$18.91
Total Value
$32.73K
Shares Held After
56,630
% of Holdings
3.1%
Twist Bioscience Corp (TWST)
CHESS ROBERT — Director
Shares
10,000
Price
$47.00
Total Value
$470.00K
Shares Held After
21,084
% of Holdings
32.2%
MAXCYTE, INC. (MXCT)
Swirsky Douglas J — CHIEF FINANCIAL OFFICER
Shares
10,142
Price
$0.81
Total Value
$8.27K
Shares Held After
151,669
% of Holdings
6.3%
Evolus, Inc. (EOLS)
MOATAZEDI DAVID — Director
Shares
116,720
Price
$4.89
Total Value
$570.56K
Shares Held After
618,369
% of Holdings
15.9%
Evolus, Inc. (EOLS)
Avelar Rui — Chief Medical Officer and Head of Research & Development
Shares
29,996
Price
$4.89
Total Value
$146.63K
Shares Held After
430,542
% of Holdings
6.5%
Vaxcyte, Inc. (PCVX)
Cowan Elvia — SVP, Finance & CAO
Shares
405
Price
$56.26
Total Value
$22.79K
Shares Held After
28,975
% of Holdings
1.4%
Vaxcyte, Inc. (PCVX)
Cowan Elvia — SVP, Finance & CAO
Shares
1,487
Price
$55.39
Total Value
$82.36K
Shares Held After
29,380
% of Holdings
4.8%
Centessa Pharmaceuticals plc (CNTA)
Anderson Karen M. — Chief People Officer
Shares
10,043
Price
$28.10
Total Value
$282.21K
Shares Held After
62,085
% of Holdings
13.9%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
19,060
Price
$13.40
Total Value
$255.40K
Shares Held After
499,258
% of Holdings
3.7%
SUPERNUS PHARMACEUTICALS, INC. (SUPN)
Bhatt Padmanabh P. — Sr. VP of IP, CSO
Shares
22,290
Price
$50.73
Total Value
$1.13M
Shares Held After
17,044
% of Holdings
56.7%
SUPERNUS PHARMACEUTICALS, INC. (SUPN)
Bhatt Padmanabh P. — Sr. VP of IP, CSO
Shares
27,710
Price
$49.95
Total Value
$1.38M
Shares Held After
39,334
% of Holdings
41.3%
IONIS PHARMACEUTICALS INC (IONS)
HOUGEN ELIZABETH L — EVP, Finance & CFO
Shares
10,172
Price
$73.21
Total Value
$744.66K
Shares Held After
82,660
% of Holdings
11.0%
CYTOKINETICS INC (CYTK)
Blum Robert I — Director
Shares
23,928
Price
$62.15
Total Value
$1.49M
Shares Held After
430,330
% of Holdings
5.3%
CYTOKINETICS INC (CYTK)
Blum Robert I — Director
Shares
12,673
Price
$62.15
Total Value
$787.63K
Shares Held After
454,258
% of Holdings
2.7%
CYTOKINETICS INC (CYTK)
Malik Fady Ibraham — EVP Research & Development
Shares
4,397
Price
$62.15
Total Value
$273.27K
Shares Held After
153,902
% of Holdings
2.8%
CYTOKINETICS INC (CYTK)
Malik Fady Ibraham — EVP Research & Development
Shares
7,636
Price
$62.15
Total Value
$474.58K
Shares Held After
158,299
% of Holdings
4.6%
CYTOKINETICS INC (CYTK)
Callos Andrew — EVP, Chief Commercial Officer
Shares
2,916
Price
$62.15
Total Value
$181.23K
Shares Held After
71,573
% of Holdings
3.9%
CYTOKINETICS INC (CYTK)
Callos Andrew — EVP, Chief Commercial Officer
Shares
5,626
Price
$62.15
Total Value
$349.66K
Shares Held After
74,489
% of Holdings
7.0%
CYTOKINETICS INC (CYTK)
Lee Sung — EVP, Chief Financial Officer
Shares
4,935
Price
$62.15
Total Value
$306.71K
Shares Held After
87,127
% of Holdings
5.4%
RECURSION PHARMACEUTICALS, INC. (RXRX)
Taylor Ben R — Chief Financial Officer
Shares
7,956
Price
$3.39
Total Value
$26.97K
Shares Held After
1,180,318
% of Holdings
0.7%
BiomX Inc. (PHGE)
Yeganeh Reuven — Director
Shares
530,000
Price
$5.00
Total Value
$2.65M
Shares Held After
0
% of Holdings
100.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
80
Price
$540.92
Total Value
$43.27K
Shares Held After
40,513
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
780
Price
$540.10
Total Value
$421.28K
Shares Held After
40,593
% of Holdings
1.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,709
Price
$539.40
Total Value
$921.83K
Shares Held After
41,373
% of Holdings
4.0%
Showing 151–200 of 1826 transactions (page 4 of 37)